// App-Quantinova.ai

32 2014 ReSS : A Feasibility and Safety Pilot Clinical Trial of Single-dose, Intravenous Estrogen for Resuscitation of Traumatic Hemorrhagic Shock: The RESCUE - Shock Study

Researchers

Presenter

  • Kareem Abdelfattah

Principal Investigators

  • David Maass

  • Christopher Madden

  • Susanne May

  • Joseph Minei

  • Judy Powell

  • Michael Ramsey

  • Jack Roberts

  • Karla Saner

  • Kevin Schug

  • Eileen Bulger

  • Paul Pepe

  • George Sopko

  • Victoria S Warren

  • Ahamed Idris

  • Scott Emerson

  • Jim Simpkins

  • Debra Egan

  • Natl Heart

  • Michael Foreman

  • David Hoyt

  • Jeff Kerby

Medical Centers

  • University of Alabama at Birmingham, Birmingham, AL

  • UTSouthwestern Medical Center, Dallas, TX

  • and Blood Inst, Bethesda, MD

  • Vanderbilt University, Nashville, TN

  • West Virginia University, Morgantown, WV

  • University of Texas, Arlington, Arlington, TX

  • American College of Surgeons, Chicago, IL

  • University of Washington, Seattle, WA

  • Baylor Health and Hosp System, Dallas, TX

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Myocardial infarction

  • Deep vein thrombosis

  • Pulmonary embolism

  • Venous thrombosis

  • Sepsis

  • Trauma

Biomarkers

  • Sex hormone binding globulin

Drug/Treatment

  • Hydroxyzine

  • Premarin tablet

Outcome

  • N/A

Study Design

  • randomized

  • double blind/blinded

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved